Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests – Business Standard
stemadminStem Cell ResearchNo comments

Tzar Labs, a molecular diagnostic company, and Mumbai-based Epigeneres Biotechnology, have claimed a breakthrough with their RNA-marker based technology for early detection of cancer rooted in stem cell biology. The blood tests, which can help determine whether cancer is absent, imminent, or present and also detect the different stages of the disease; will be launched by the end of this year. Ashish Tripathi, founder and CEO of Tzar Labs, said that they are awaiting the regulatory approvals, and are building the first laboratory in Mumbai now.

Read more
EB Research Partnership Receives $150,000 Donation from ELONGATE to Launch the #CryptoForCures Fund to Cure Epidermolysis Bullosa – PRNewswire
stemadminStem Cell ResearchNo comments

NEW YORK, May 17, 2021 /PRNewswire/ --EB Research Partnership, the largest global nonprofit funding research to discover treatments and cures for Epidermolysis Bullosa (EB), today announces a $150,000 donation from Elongate, a cryptocurrency token focused on charitable giving, as the inaugural gift for the nonprofit's #CryptoForCures Fund, establishing Elongate as the Founding Member.

Read more
Regenerative Medicine Market Size to Reach USD 23.57 Billion by 2027; CAGR of 15.6% | Global Analysis, Statistics, Revenue, Demand and Trend Analysis…
stemadminStem Cell ResearchNo comments

Increased incidence of genetic disorders and chronic diseases is projected to drive demand for regenerative medicine during the forecast period. The globalregenerative medicine marketis forecasted to reach a market size of USD 23.57 Billion by 2027, and register a significantly rapid revenue growth rate, according to a new report by Reports and Data

Read more
Cancer Stem Cell Therapy Market Extensive Growth Opportunities to Be Witnessed by 2021-2027 KSU | The Sentinel Newspaper – KSU | The Sentinel…
stemadminStem Cell ResearchNo comments

Cancer Stem Cell Therapy market research report provides detailed information on the following aspects: industry size, share, growth, segmentation, manufacturers and progress, main trends, market drivers, challenges, standardization, deployment models, opportunities, strategies, future roadmaps, and Annual forecast till 2026, etc. The report conducted a professional and in-depth analysis of the current situation of the Cancer Stem Cell Therapy market, including major players such as manufacturers, suppliers, distributors, traders, customers, and investors. The report also helps you understand the dynamic structure of the Cancer Stem Cell Therapy market by identifying and analyzing market segments.

Read more
The Worldwide Stem Cell Therapy Industry is Projected to Reach $401 Million by 2026 at a CAGR of 16.5% from 2021 – PRNewswire
stemadminStem Cell ResearchNo comments

DUBLIN, May 14, 2021 /PRNewswire/ -- The "Global Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering. The global stem cell therapy market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period. Growth in this market is majorly driven by the increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants.However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market

Read more
Global Stem Cell Reconstructive Market 2021 Top Players Osiris Therapeutics, NuVasive, Cytori Therapeutics, Takeda (TiGenix), Cynata, Celyad,…
stemadminStem Cell ResearchNo comments

MarketQuest.biz presents the top quality and comprehensive research on Global Stem Cell Reconstructive Market 2021 by Company, Regions, Type and Application, Forecast to 2026 which offers a detailed survey of the market in communicative format, covering the past data and calculating 2021-2026. The report throws light on some of the leading factors related to the global Stem Cell Reconstructive market.

Read more
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs…
stemadminStem Cell ResearchNo comments

CRANBURY, N.J.--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces positive clinical data from its Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), and Pyruvate Kinase Deficiency (PKD) gene therapy programs presented at the 24th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Read more

Theme: Illdy.